Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449507) titled 'Partially Hydrolyzed Whey Protein Formula for Infants With Mild Allergy' on Feb. 27.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Ruijin Hospital

Condition: Mild Allergic Symptoms in Infants Infant Feeding Intolerance

Intervention: Dietary Supplement: Partially Hydrolyzed Whey Protein Formula

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: April 1, 2026

Target Sample Size: 160

To know more, visit https://clinicaltrials.gov/study/NCT07449507

Disc...